ZNTLZentalis Pharmaceuticals, Inc.
- Market cap
- $216.85M
- as of 2026-10-23
- Latest close
- $2.21
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Biotechnology
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2023-10-06
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Bruns IngmarChief Medical Officer | Sep 30 | Oct 1 | A | 9,727 | $2.18 | $21,205 | 43,059 | No | Form 4 |
| Walters William Thurman | Aug 14 | Aug 19 | P | 4,335,000 | $3.50 | Purchase +$15,172,500 | 17,844,973 | No | Form 4 |
| Myers Scott Dunseth | Jun 16 | Jun 18 | A | 57,100 | $0.00 | $0 | 395,895 | No | Form 4 |
| Walker Luke Nathaniel | Jun 16 | Jun 18 | A | 57,100 | $0.00 | $0 | 201,384 | No | Form 4 |
| Johnson David Michael | Jun 16 | Jun 18 | A | 57,100 | $0.00 | $0 | 307,521 | No | Form 4 |
| Skvarka Jan | Jun 16 | Jun 18 | A | 57,100 | $0.00 | $0 | 264,254 | No | Form 4 |
| Kariuki Enoch | Jun 16 | Jun 18 | A | 57,100 | $0.00 | $0 | 194,465 | No | Form 4 |
| Campbell Shannon | May 26 | May 27 | A | 114,200 | $0.00 | $0 | 114,200 | No | Form 4 |
| Vultaggio VincentPAO and PFO | Feb 10 | Feb 10 | S | 6,894 | $2.42 | Sale −$16,683 | 146,506 | Yes | Form 4 |
| Eastland Julia MarieCEO & President | Feb 9 | Feb 10 | S | 889 | $2.39 | Sale −$2,125 | 79,133 | No | Form 4 |
| Bruns IngmarChief Medical Officer | Feb 9 | Feb 10 | S | 335 | $2.39 | Sale −$801 | 33,332 | No | Form 4 |
| Vultaggio VincentPAO and PFO | Feb 9 | Feb 10 | S | 3,379 | $2.39 | Sale −$8,076 | 153,400 | Yes | Form 4 |
| Eastland Julia MarieCEO & President | Feb 6 | Feb 10 | S | 7,866 | $2.43 | Sale −$19,114 | 80,022 | No | Form 4 |
| Bruns IngmarChief Medical Officer | Feb 6 | Feb 10 | S | 2,962 | $2.43 | Sale −$7,198 | 33,667 | No | Form 4 |
| Vultaggio VincentPAO and PFO | Feb 6 | Feb 10 | S | 29,951 | $2.43 | Sale −$72,781 | 156,779 | Yes | Form 4 |
| Vultaggio VincentPAO and PFO | Feb 3 | Feb 4 | S | 556 | $2.52 | Sale −$1,401 | 186,730 | Yes | Form 4 |
| Vultaggio VincentPAO and PFO | Feb 2 | Feb 4 | S | 2,540 | $2.55 | Sale −$6,477 | 187,286 | Yes | Form 4 |
| Eastland Julia MarieCEO & President | Jan 8 | Jan 9 | A · derivative | 775,000 | $2.84 | $2,201,000 | 775,000 | No | Form 4 |
| Bucher James BChief Legal Officer | Jan 8 | Jan 9 | A · derivative | 100,000 | $2.84 | $284,000 | 100,000 | No | Form 4 |
| Bruns IngmarChief Medical Officer | Jan 8 | Jan 9 | A · derivative | 365,000 | $2.84 | $1,036,600 | 365,000 | No | Form 4 |
| Vultaggio VincentPAO and PFO | Jan 8 | Jan 9 | A · derivative | 100,000 | $2.84 | $284,000 | 100,000 | No | Form 4 |
| Walters William Thurman | Dec 31, 2025 | Jan 8 | P | 6,459,973 | $1.20 | Purchase +$7,751,968 | 13,509,973 | No | Form 4 |
| Goel David E. | Dec 15, 2025 | Dec 15, 2025 | S | 7,500,000 | $1.33 | Sale −$9,975,000 | 6,459,973 | No | Form 4 |
| Bucher James BChief Legal Officer | Oct 1, 2025 | Oct 1, 2025 | A · derivative | 400,000 | $1.54 | $616,000 | 400,000 | No | Form 4 |
| Myers Scott Dunseth | Jun 17, 2025 | Jun 18, 2025 | A | 57,603 | $0.00 | $0 | 338,795 | No | Form 4 |
| Kariuki Enoch | Jun 17, 2025 | Jun 18, 2025 | A | 57,603 | $0.00 | $0 | 137,365 | No | Form 4 |
| Johnson David Michael | Jun 17, 2025 | Jun 18, 2025 | A | 57,603 | $0.00 | $0 | 250,421 | No | Form 4 |
| Skvarka Jan | Jun 17, 2025 | Jun 18, 2025 | A | 57,603 | $0.00 | $0 | 207,154 | No | Form 4 |
| Walker Luke Nathaniel | Jun 17, 2025 | Jun 18, 2025 | A | 57,603 | $0.00 | $0 | 144,284 | No | Form 4 |
| Myers Scott Dunseth | Apr 30, 2025 | Apr 30, 2025 | P | 21,000 | $1.40 | Purchase +$29,400 | 281,192 | No | Form 4 |
| Bruns IngmarChief Medical Officer | Feb 6, 2025 | Feb 12, 2025 | P | 20,000 | $2.28 | Purchase +$45,600 | 36,629 | No | Form 4 |
| Eastland Julia MarieCEO & President | Feb 3, 2025 | Feb 5, 2025 | A | 59,388 | $0.00 | $0 | 87,888 | No | Form 4 |
| Eastland Julia MarieCEO & President | Feb 3, 2025 | Feb 5, 2025 | A · derivative | 59,388 | $1.68 | $99,772 | 59,388 | No | Form 4 |
| Bruns IngmarChief Medical Officer | Feb 3, 2025 | Feb 5, 2025 | A | 16,629 | $0.00 | $0 | 16,629 | No | Form 4 |
| Bruns IngmarChief Medical Officer | Feb 3, 2025 | Feb 5, 2025 | A · derivative | 16,629 | $1.68 | $27,937 | 16,629 | No | Form 4 |
| Paul AndreaChief Legal Officer | Feb 3, 2025 | Feb 5, 2025 | A | 934,041 | $0.00 | $0 | 1,084,014 | No | Form 4 |
| Paul AndreaChief Legal Officer | Feb 3, 2025 | Feb 5, 2025 | S | 13,230 | $1.71 | Sale −$22,623 | 1,070,784 | No | Form 4 |
| Paul AndreaChief Legal Officer | Feb 3, 2025 | Feb 5, 2025 | A · derivative | 124,714 | $1.68 | $209,520 | 124,714 | No | Form 4 |
| Lackner MarkChief Scientific Officer | Feb 3, 2025 | Feb 5, 2025 | A | 335,907 | $0.00 | $0 | 527,224 | No | Form 4 |
| Lackner MarkChief Scientific Officer | Feb 3, 2025 | Feb 5, 2025 | S | 14,368 | $1.71 | Sale −$24,569 | 512,856 | No | Form 4 |
| Lackner MarkChief Scientific Officer | Feb 3, 2025 | Feb 5, 2025 | A · derivative | 124,714 | $1.68 | $209,520 | 124,714 | No | Form 4 |
| Vultaggio VincentPAO and Interim PFO | Feb 3, 2025 | Feb 5, 2025 | A | 158,586 | $0.00 | $0 | 192,441 | No | Form 4 |
| Vultaggio VincentPAO and Interim PFO | Feb 3, 2025 | Feb 5, 2025 | S | 2,615 | $1.71 | Sale −$4,472 | 189,826 | No | Form 4 |
| Vultaggio VincentPAO and Interim PFO | Feb 3, 2025 | Feb 5, 2025 | A · derivative | 35,633 | $1.68 | $59,863 | 35,633 | No | Form 4 |
| Eastland Julia MarieCEO & President | Jan 31, 2025 | Feb 4, 2025 | P | 28,500 | $1.73 | Purchase +$49,305 | 28,500 | No | Form 4 |
| Walker Luke Nathaniel | Jan 31, 2025 | Feb 4, 2025 | P | 14,200 | $1.76 | Purchase +$24,992 | 86,681 | No | Form 4 |
| Skvarka Jan | Jan 31, 2025 | Feb 4, 2025 | P | 60,000 | $1.72 | Purchase +$103,200 | 149,551 | No | Form 4 |
| Lackner MarkChief Scientific Officer | Jan 2, 2025 | Jan 3, 2025 | S | 4,411 | $3.12 | Sale −$13,762 | 191,317 | No | Form 4 |
| Eastland Julia MarieCEO & President | Dec 2, 2024 | Dec 3, 2024 | A · derivative | 3,028,800 | $3.66 | $11,085,408 | 3,028,800 | No | Form 4 |
| Bruns IngmarChief Medical Officer | Dec 2, 2024 | Dec 3, 2024 | A · derivative | 712,650 | $3.66 | $2,608,299 | 712,650 | No | Form 4 |
| Myers Scott Dunseth | Nov 13, 2024 | Nov 13, 2024 | A | 260,192 | $0.00 | $0 | 260,192 | No | Form 4 |
| Vultaggio VincentPrincipal Accounting Officer | Oct 4, 2024 | Oct 4, 2024 | S | 1,603 | $3.18 | Sale −$5,098 | 33,855 | Yes | Form 4 |
| Johnson David Michael | Jun 21, 2024 | Jun 21, 2024 | A | 48,429 | $0.00 | $0 | 192,818 | No | Form 4 |
| Kariuki Enoch | Jun 21, 2024 | Jun 21, 2024 | A | 41,581 | $0.00 | $0 | 79,762 | No | Form 4 |
| Skvarka Jan | Jun 21, 2024 | Jun 21, 2024 | A | 41,581 | $0.00 | $0 | 89,551 | No | Form 4 |
| Gallagher CamPresident, Interim CFO | May 31, 2024 | May 31, 2024 | S | 9,597 | $11.98 | Sale −$114,972 | 633,680 | No | Form 4 |
| Walker Luke Nathaniel | May 24, 2024 | May 29, 2024 | A | 72,481 | $0.00 | $0 | 72,481 | No | Form 4 |
| Hausman DianaChief Medical Officer | May 9, 2024 | May 9, 2024 | S | 3,356 | $12.62 | Sale −$42,353 | 373,876 | No | Form 4 |
| Gallagher CamPresident | Feb 12, 2024 | Feb 12, 2024 | S | 1,173 | $11.44 | Sale −$13,419 | 643,277 | No | Form 4 |
| Epperly Melissa B,Chief Financial Officer | Feb 12, 2024 | Feb 12, 2024 | S | 2,573 | $11.44 | Sale −$29,435 | 451,449 | No | Form 4 |
| Epperly Melissa B,Chief Financial Officer | Feb 2, 2024 | Feb 5, 2024 | S | 8,669 | $11.54 | Sale −$100,040 | 454,022 | No | Form 4 |
| Gallagher CamPresident | Feb 2, 2024 | Feb 5, 2024 | S | 11,552 | $11.54 | Sale −$133,310 | 644,450 | No | Form 4 |
| Paul AndreaChief Legal Officer | Feb 2, 2024 | Feb 5, 2024 | S | 3,310 | $11.54 | Sale −$38,197 | 149,973 | No | Form 4 |
| Lackner MarkChief Scientific Officer | Feb 2, 2024 | Feb 5, 2024 | S | 1,585 | $11.54 | Sale −$18,291 | 195,728 | No | Form 4 |
| Blackwell KimberlyChief Executive Officer | Feb 1, 2024 | Feb 5, 2024 | A | 250,000 | $0.00 | $0 | 504,800 | No | Form 4 |
| Blackwell KimberlyChief Executive Officer | Feb 1, 2024 | Feb 5, 2024 | F | 20,655 | $11.69 | $241,457 | 484,145 | No | Form 4 |
| Blackwell KimberlyChief Executive Officer | Feb 1, 2024 | Feb 5, 2024 | A · derivative | 250,000 | $11.69 | $2,922,500 | 250,000 | No | Form 4 |
| Epperly Melissa B,Chief Financial Officer | Feb 1, 2024 | Feb 5, 2024 | A | 75,000 | $0.00 | $0 | 462,691 | No | Form 4 |
| Epperly Melissa B,Chief Financial Officer | Feb 1, 2024 | Feb 5, 2024 | A · derivative | 75,000 | $11.69 | $876,750 | 75,000 | No | Form 4 |
| Gallagher CamPresident | Feb 1, 2024 | Feb 5, 2024 | A | 192,500 | $0.00 | $0 | 656,002 | No | Form 4 |
| Gallagher CamPresident | Feb 1, 2024 | Feb 5, 2024 | A · derivative | 192,500 | $11.69 | $2,250,325 | 192,500 | No | Form 4 |
| Paul AndreaChief Legal Officer | Feb 1, 2024 | Feb 5, 2024 | A | 112,500 | $0.00 | $0 | 153,283 | No | Form 4 |
| Paul AndreaChief Legal Officer | Feb 1, 2024 | Feb 5, 2024 | A · derivative | 112,500 | $11.69 | $1,315,125 | 112,500 | No | Form 4 |
| Paul AndreaChief Legal Officer | Feb 1, 2024 | Feb 5, 2024 | A · derivative | 90,000 | $11.69 | $1,052,100 | 90,000 | No | Form 4 |
| Lackner MarkChief Scientific Officer | Feb 1, 2024 | Feb 5, 2024 | A | 141,000 | $0.00 | $0 | 197,313 | No | Form 4 |
| Lackner MarkChief Scientific Officer | Feb 1, 2024 | Feb 5, 2024 | A · derivative | 141,000 | $11.69 | $1,648,290 | 141,000 | No | Form 4 |
| Hausman DianaChief Medical Officer | Feb 1, 2024 | Feb 5, 2024 | A | 337,500 | $0.00 | $0 | 377,232 | No | Form 4 |
| Hausman DianaChief Medical Officer | Feb 1, 2024 | Feb 5, 2024 | A · derivative | 337,500 | $11.69 | $3,945,375 | 337,500 | No | Form 4 |
| Lackner MarkChief Scientific Officer | Jan 2, 2024 | Jan 3, 2024 | A | 40,000 | $0.00 | $0 | 56,313 | No | Form 4 |
| Lackner MarkChief Scientific Officer | Jan 2, 2024 | Jan 3, 2024 | A · derivative | 60,000 | $15.99 | $959,400 | 60,000 | No | Form 4 |
| Bunker Kevin D.Chief Scientific Officer | Dec 20, 2023 | Dec 21, 2023 | G | 24,158 | $0.00 | $0 | 834,931 | No | Form 4 |
| Blackwell KimberlyChief Executive Officer | Nov 13, 2023 | Nov 13, 2023 | P | 5,000 | $10.29 | Purchase +$51,450 | 254,800 | No | Form 4 |
| Johnson David Michael | Nov 10, 2023 | Nov 13, 2023 | P | 17,000 | $9.88 | Purchase +$167,960 | 144,389 | No | Form 4 |
| Epperly Melissa B,Chief Financial Officer | Oct 4, 2023 | Oct 6, 2023 | S | 4,594 | $19.43 | Sale −$89,261 | 388,579 | Yes | Form 4 |
| Epperly Melissa B,Chief Financial Officer | Oct 4, 2023 | Oct 6, 2023 | S | 888 | $19.91 | Sale −$17,680 | 387,691 | Yes | Form 4 |
| Bunker Kevin D.Chief Scientific Officer | Oct 4, 2023 | Oct 6, 2023 | S | 5,085 | $19.43 | Sale −$98,802 | 860,072 | Yes | Form 4 |
| Bunker Kevin D.Chief Scientific Officer | Oct 4, 2023 | Oct 6, 2023 | S | 983 | $19.91 | Sale −$19,572 | 859,089 | Yes | Form 4 |
| Brownstein CarrieChief Medical Officer | Oct 4, 2023 | Oct 6, 2023 | S | 8,906 | $19.43 | Sale −$173,044 | 107,407 | Yes | Form 4 |
| Brownstein CarrieChief Medical Officer | Oct 4, 2023 | Oct 6, 2023 | S | 1,722 | $19.91 | Sale −$34,285 | 105,685 | Yes | Form 4 |